Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 1

Conditions

Prostatic Neoplasms 17Neoplasms 13Breast Neoplasms 12Neuroendocrine Tumors 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Neoplasm Metastasis 6Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Multiple Myeloma 4Rectal Neoplasms 3Pancreatic Neoplasms 3Mouth Neoplasms 3Lymphoma, Non-Hodgkin 3Glioma 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Nasopharyngeal Carcinoma 2Multiple Pulmonary Nodules 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Liver Neoplasms 2Leukemia 2Hypoxia 2Hematologic Neoplasms 2Head and Neck Neoplasms 2

Interventions

Cyclophosphamide 328Methotrexate 182Cytarabine 164fludarabine phosphate 151Vincristine 128Dexamethasone 126fludarabine 123Peripheral Blood Stem Cell Transplantation 116Whole-Body Irradiation 108Etoposide 106Mycophenolic Acid 105Tacrolimus 95Busulfan 95Filgrastim 93Melphalan 81Cyclosporine 80Rituximab 79Doxorubicin 79Mercaptopurine 69Radiotherapy 62Antilymphocyte Serum 62Granulocyte Colony-Stimulating Factor 57Prednisone 56blinatumomab 55pegaspargase 54Asparaginase 54Thiotepa 52Daunorubicin 52Calcium Dobesilate 47Clofarabine 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Positron Emission Tomography Computed Tomography × Clear all
NCT03429387 2022-05-17

PIPPIN

Peter MacCallum Cancer Centre, Australia

Phase NA Completed
147 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
80 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡